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Regulation of serum response factor (SRF)-mediated
gene transcription by G protein subunits and G protein-
coupled receptors was investigated in transfected
NIH3T3 cells and in a cell line that was derived from
mice lacking Gaq and Ga11. We found that the constitu-
tively active forms of the a subunits of the Gq and G12
class of G proteins, including Gaq, Ga11, Ga14, Ga16, Ga12,
and Ga13, can activate SRF in NIH3T3 cells. We also
found that the type 1 muscarinic receptor (m1R) and
a1-adrenergic receptor (AR)-mediated SRF activation is
exclusively dependent on Gaq/11, while the receptors for
thrombin, lysophosphatidic acid (LPA), thromboxane
A2, and endothelin can activate SRF in the absence of
Gaq/11. Moreover, RGS12 but not RGS2, RGS4, or Axin
was able to inhibit Ga12 and Ga13-mediated SRF activa-
tion. And RGS12, but not other RGS proteins, blocked
thrombin- and LPA-mediated SRF activation in the
Gaq/11-deficient cells. Therefore, the thrombin, LPA,
thromboxane A2, and endothelin receptors may be able
to couple to Ga12/13. On the contrary, receptors includ-
ing b2- and a2-ARs, m2R, the dopamine receptors type 1
and 2, angiotensin receptors types 1 and 2, and interleu-
kin-8 receptor could not activate SRF in the presence or
absence of Gaq/11, suggesting that these receptors can-
not couple to endogenous G proteins of the G12 or Gq
classes.
Hormones, neurotransmitters, and many other biologically
active molecules, such as lysophosphatidic acid (LPA),1 throm-
bin, catecholamines, endothelin, etc., transduce their signals
through heterotrimeric G proteins (1, 2). Molecular cloning has
revealed at least four classes of G protein a subunits: Gas, Gai,
Gaq, and Ga12 (3). The Gas subunits and Gai subunits regulate
adenylyl cyclase activities, while the Gaq subunits regulate
phospholipase C activities. However, the function of the Ga12
class of G proteins, which includes Ga12 and Ga13, remains to
be elucidated. Activated forms of Ga12 and Ga13, when trans-
fected into fibroblast cells, were shown to induce transforma-
tion phenotypes (4–6), suggesting that this class of G proteins
may be involved in cell growth regulation. Moreover, Ga12 and
Ga13 were shown to induce formation of stress fibers in fibro-
blast cells through small G protein RhoA (7). This observation
was supported by the report that Ga12 activated serum re-
sponse factor (SRF) through RhoA (8). The in vivo function of
Ga13 was also investigated using the gene-targeting technique
in mice. Mice lacking Ga13 are embryonic lethal apparently due
to the failure to develop vasculature structures, indicating that
Ga13 may be involved in the function of endothelial cells (9). In
the same study, thrombin-mediated chemotaxis of fibroblasts
lacking Ga13 was blocked, indicating that the thrombin recep-
tor couples to Ga13. This is consistent with the observation that
thrombin as well as a thromboxane A2 receptor agonist could
stimulate the binding of a photo-affinity GTP analog to Ga13
(10). However, there were contradictory reports with regard to
the involvement of the Gq class of G proteins in RhoA and SRF
activation (7, 8, 16).
RGS (regulator of G protein signaling) proteins belong to a
growing family of proteins that contains homologous RGS do-
mains (11, 12). Some of these proteins such as GIAP and RGS4
were shown to inhibit G protein-mediated signaling by inter-
acting with the Gai and Gao subunits and stimulating their
GTPase activities (13), which are also referred to as GTPase-
activating protein activities. RGS2 and RGS4 were found to
inhibit Gaq-mediated activation of phospholipase Cb (14–16),
implying that they may function as GTPase-activating protein
for Gaq. Interestingly, most of these RGS proteins were unable
to inhibit Gs-mediated signaling, and they could not stimulate
the GTPase activity of the Gas proteins (13, 14). Regulation of
the G12/13 proteins by RGS proteins has not been investigated.
In this report, we characterized the abilities of the G protein
subunits and of a number of GPCRs to stimulate SRF-mediated
gene transcription using a cotransfection system. We found
that the a subunits of the Gq and G12 classes of G proteins can
induce SRF activation in a C3-dependent manner. We also
found that the activation of SRF by some of GPCRs depends
exclusively on Gaq/11, while others do not. Those that activate
SRF independently of Gaq/11 may act through Ga12/13. In addi-
tion, we, for the first time, identified a RGS protein, RGS12,
that can inhibit the Ga12/13 function.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and Luciferase Assay—-NIH3T3 and the
Gaq/11-deficient cells were maintained in Dulbecco’s modified Eagle’s
medium containing 10% fetal calf serum at 37 °C under 5% CO2. The
Gaq/11-deficient cell line was established from mice lacking both Gaq
and Ga11 (17). For transfection, cells (5 3 10
4 cells/well) were seeded
into 24-well plates the day before transfection. Cells were transfected
with 0.5 mg of DNA/well using LipofectAMINE Plus (Life Technologies,
Inc.), as suggested by the manufacturer. The transfection was stopped
after 3 h by switching to culture medium containing 0.5% fetal bovine
serum. Cell extracts were collected 24 h later for luciferase assays.
* This work was supported by National Institutes of Health Grants
GM53162 and GM54167 and by the National Heart Association (to
D. W.). The costs of publication of this article were defrayed in part by
the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
§ To whom correspondence should be addressed. E-mail:
wud@pharmacol.rochester.edu.
1 The abbreviations used are: LPA, lysophosphatidic acid; AR, adre-
nergic receptor; AT, angiotensin; C3, C. butulinum C3 transferase;
CRE, cAMP response element; LacZ, b-galactosidase; GPCR, G protein-
coupled receptors; IL-8, interleukin-8; m1R and m2R, muscarinic cho-
linergic receptor type 1 and type 2, respectively; Ptx, pertussis toxin;
RGS, regulator of G protein signaling; SRE, serum response element;
SRF, serum response factor; GFP, green fluorescence protein.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 273, No. 42, Issue of October 16, pp. 27118–27123, 1998
© 1998 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org27118
Luciferase assays were performed using Boehringer Mannheim Con-
stant Light Luciferase Assay Kit as instructed. Cell lysates were first
taken for determining in a Wallac multicounter the fluorescence inten-
sity emitted by GFP proteins, which are cotransfected with the lucifer-
ase reporter gene plasmid and used to normalize the transfection effi-
ciency. The Wallac counter (Wallac AG&G, Finland) is capable of
counting both fluorescence and luminescence. Then, the luciferase sub-
strate was added to the cell lysates, and luciferase activities were
determined by measuring luminescence intensity using the same coun-
ter. Luminescence intensities were normalized against fluorescence
intensities. DNA concentrations were adjusted if transfection of any of
the cDNAs resulted in significant differences between normalized and
non-normalized data.
Construction of Expression Plasmids—All of the G protein subunits
and GPCRs were in pCMV expression vectors as described previously
(18–20). The SRE.L-luciferase reporter plasmid was constructed as
described in Ref. 7, except the luciferase gene was used as the reporter
instead of the chloramphenicol acetyltransferase gene. The CRE-lucif-
erase reporter gene plasmid was purchased from Strategene, La Jolla,
CA. RGS2, RGS4, and RGS12 (kindly provided by Sheng-Cai Lin) were
also in the pCMV vector. Axin (kindly provided by F. Costantini) was in
the pcDNA3 vector (Invitrogen). C3 was kindly provided by Alan Hall.
RESULTS
A cotransfection system was used to characterize signal
transduction pathways mediated by G proteins that lead to the
regulation of SRF-dependent gene transcription. SRF-medi-
ated gene transcription was evaluated by determining the ac-
tivity of luciferase, the production of which is regulated by a
transcription regulatory sequence element, called SRE.L.
SRE.L is a derivative of c-Fos serum response element (SRE),
to which SRF but not tertiary complex factor binds (21). Thus,
SRE.L-mediated production of luciferase mainly depends on
the activity of SRF. The abilities of various G protein subunits
to regulate SRE.L-mediated gene transcription were deter-
mined by cotransfecting NIH3T3 cells with the reporter gene
plasmid and cDNA encoding one of constitutively active Ga
subunits. We found that cells expressing activated a subunit of
Gq, G11, G14, G16, G12, or G13, produced markedly higher levels
of luciferase than those expressing the control b-galactosidase
(LacZ), whereas expression of activated Gai or Gao did not (Fig.
1). This indicates that the a subunits of the Gq and G12 classes
of G proteins can lead to SRF activation. The finding that C3
blocked SRF activation by the G protein a subunits suggests
that the small GTP-binding protein RhoA (Fig. 1) may mediate
the SRF activation. C3 (Clostridium butulinum C3 transferase)
is a specific RhoA inactivator, which ADP-ribosylates RhoA
(21). In our transfection system, C3 inhibited only RhoA-in-
duced but not Cdc42- (Fig. 1) or Rac1- (data not shown) induced
SRF activation, indicating that C3 acted specifically.
Activation of SRF by the Gq and G12 family of G proteins
allows us to determine which receptors can couple to these G
proteins to activate SRF. Many cells, including fibroblasts,
contain endogenous receptors for thrombin and LPA, which
belong to a superfamily of GPCR. In addition, the thrombin
receptor was shown previously to couple to the G12/13 proteins
(10) so that it may function as a positive control. We found that
both thrombin and LPA were able to stimulate SRE.L-medi-
ated gene transcription in NIH3T3 cells transfected with the
reporter gene plasmids (Fig. 2A). This result suggests that
NIH3T3 cells contain endogenous receptors for thrombin and
LPA. A number of other GPCRs were also tested for their
abilities to stimulate SRE.L-mediated gene transcription in
transfected 3T3 cells. Cells expressing m1R and a1-AR showed
marked increases in luciferase activities in response to carba-
chol and norepinephrine, respectively (Fig. 1B). Neither carba-
chol nor norepinephrine elicited any change in the luciferase
activity in cells transfected with the reporter gene plasmid
alone (Fig. 1A), indicating that there are no endogenous recep-
tors for carbachol and norepinephrine in NIH3T3 cells. A mu-
tant of a1-AR, a1-ARD2, was also tested in the same cotrans-
fection system. a1-ARD2, which was unable to couple to Gaq/11
to activate phospholipase C (22), lost the ability to activate SRF
in the presence of ligand norepinephrine. This suggests that
a1-AR-mediated SRF activation appears to depend on Gaq/11 in
fibroblasts. The fact that the expression of C3 was able to
abolish thrombin-, LPA-, norepinephrine-, and carbachol-in-
duced SRF activation suggests that the SRF activation by these
ligands be mediated by RhoA (Fig. 2, A and B). Furthermore,
we tested Gi-coupling m2R and IL-8 receptor and Gs-coupling
b2-AR. None of these receptors was able to stimulate SRF
activity in response to their ligands (Fig. 2B). These results are
consistent with the observation that the Gi and Go are not
involved in regulation of SRF.
FIG. 1. Regulation of SRF-mediated gene transcription by G protein subunits. NIH3T3 cells were cotransfected with 0.15 mg of
SRE.L-luciferase reporter plasmid, 0.15 mg of GFP expression construct, and 0.2 mg of LacZ and activated Cdc42V12 or RhoV14 or 0.01 mg of
various activated forms of G protein subunits in the presence or absence of 0.02 mg of C3 expression plasmid. LacZ expression plasmid was used
to make up the total amount of DNA equal in all transfections. One day later, cells were lysed, and GFP levels and luciferase activities were
determined. The luciferase activities presented are normalized against the levels of GFP expression. Data show similar tendencies with or without
normalization. Experiments were carried out in triplicate and repeated at least twice. The representative experiments are shown, and error bars
represent S.D. values.
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It has been demonstrated by various approaches that m1R
and a1-AR couple to the Gq proteins (18, 23). Although the
receptors for thrombin and LPA have not been rigorously
tested for their abilities to couple to the G proteins of the Gq
family, they were shown previously to stimulate inositol phos-
phate accumulation (24), suggesting that they may couple to
the Gq proteins. To test the roles of Gaq/11 in SRF activation by
these receptors, a fibroblast cell line derived from mice lacking
Gq/11 was used. Thrombin, LPA, carbachol, and norepinephrine
were added to the Gaq/11-deficient cells that were transfected
with the SRE.L-luciferase reporter gene plasmid. Both throm-
bin and LPA were able to stimulate SRE.L-mediated gene
transcription, which can be blocked by C3 (Fig. 3A). Thrombin
and LPA showed EC50 values of about 5 units and 4 mM in
stimulation of luciferase activities, respectively (Fig. 4, A and
B). Thus, this cell line, like NIH3T3 cells, also contains endog-
enous thrombin and LPA receptors, and the receptors for
thrombin and LPA are able to activate SRF independent of
Gaq/11. The Gaq/11-deficient cells were also cotransfected with
the cDNA encoding the thrombin receptor and the reporter
gene plasmid, and cells expressing the recombinant thrombin
receptors showed higher thrombin-induced production of lucif-
erase than those transfected with the control plasmid (Fig. 3A).
Therefore, both endogenous and recombinant thrombin recep-
tors are able to activate SRF in a Gaq/11-independent way.
The inability of norepinephrine and carbachol to elicit re-
porter gene transcription (data not shown) may be due to the
lack of endogenous receptors. Therefore, these two ligands were
tested in the Gaq/11-deficient cells transiently expressing a1-AR
and m1R, respectively. The ligands were still unable to elicit
responses, even in the presence of the recombinant receptors
(Fig. 3B). However, the responses of cells to norepinephrine
were restored when Gaq was reintroduced back into the
Gaq/11-deficient cells by cotransfection with a1-AR and the re-
porter gene (Fig. 3B). The same result was also observed for
carbachol when m1R and Gaq were coexpressed in the Gaq/11-
deficient cells (Fig. 3B). Therefore, we conclude that a1-AR and
m1R are dependent exclusively on Gaq/11 in SRF activation.
This conclusion further strengthens the idea that the Gq pro-
teins are capable of activating RhoA and SRF. Since a1-AR is
able to couple to all the members of the Gq class of G proteins,
including Ga14 and Ga16 (19), the inability of a1-AR to activate
SRF in the Gaq/11-deficient cell line suggests that there are not
sufficient levels of endogenous Ga14 and Ga16 in this cell line.
Thus, if any receptor can induce SRF activation in this cell line,
it would suggest that this receptor is able to couple to G pro-
teins other than the Gq class, which would be the G12/13 pro-
teins. Thus, the Gaq/11-deficient cell line may be used for test-
ing the coupling of receptors to the G proteins of the G12 class.
We tested a number of receptors in this Gaq/11-deficient cell
line, including the endothelin receptors 1a and 1b, thrombox-
ane A2 receptor, angiotensin (AT) receptors type 1a and type 2,
a2- and b2-AR, and dopamine receptors type 1 and 2. Endothe-
lin was able to activate the SRF.L-mediated gene transcription
FIG. 2. Regulation of SRF-mediated gene transcription by
GPCRs in NIH 3T3 cells. A, NIH3T3 cells were cotransfected with
0.15 mg of SRE.L-luciferase reporter plasmid, 0.15 mg of GFP expression
construct, and 0.2 mg of LacZ in the presence or absence of 0.02 mg of the
C3 expression plasmid. B, NIH3T3 cells were transfected the same as A
in addition to various GPCRs (0.2 mg). The next day, cells were lysed 6 h
after the addition of ligands. 10 units/ml thrombin (Thr), 5 mM LPA, or
a mixture of 1 mM carbachol (Car) and 1 mM norepinephrine (Nor) was
added (A). 1 mM carbachol, 1 mM norepinephrine, 50 nM IL-8 and 10 mM
isoprenaline were added to cells expressing the muscarinic receptors,
a1- and a2-ARs, IL-8 receptor, and b2-AR, respectively (B). Data are
processed and presented as described in the legend to Fig. 1.
FIG. 3. Regulation of SRF-mediated gene transcription by
GPCRs in the Gaq/11-deficient cells. A, the Gq/11-deficient cells were
cotransfected with 0.15 mg of SRE.L-luciferase reporter plasmid, 0.15
mg of GFP expression construct, and 0.2 mg of LacZ in the presence
(black bars) or absence (open bars) of 0.02 mg of C3 expression plasmid.
B and C, the Gq/11-deficient cells were transfected the same as in A in
addition to various GPCRs (0.2 mg). The next day cells were lysed 6 h
after the addition of ligands as described in Fig. 2, except 10 nM U46619,
100 nM angiotensin, and 1 mM dopamine were added into cells express-
ing the thromboxane A2 receptor (Tx2), angiotensin receptors (AT), and
dopamine receptor (DR) type 1, respectively. Data are processed and
presented as described in the legend to Fig. 1.
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in cells expressing endothelin receptor 1a (Fig. 3C) or 1b (data
not shown) with EC50 values of about 0.25 nM (Fig. 4C and data
not shown), while the thromboxane A2 receptor agonist
U46619 gave an EC50 value of 1 nM (Figs. 3C and 4D). Angio-
tensin, norepinephrine, isoprenaline, and dopamine failed to
elicit any SRF activation in cells expressing AT receptors,
a1-AR, b2-AR, and dopamine receptors, respectively (Fig. 3C).
These results suggest that endothelin receptors and the throm-
boxane A2 receptor may be able to couple to G12/13.
The effects of Gbg subunits on SRF activation were also
tested in the same cotransfection system. Cells coexpressing b1
and g1 or b1 and g5 showed approximately 1-fold more lucifer-
ase activity than those expressing the control LacZ (Fig. 5A).
This result suggests that Gbg subunits may also be involved in
regulation of SRF, but with less potency than the Gaq and Ga12
subunits. To further investigate the role of Gbg in SRF activa-
tion, we tested if Gbg has any effect on Ga-mediated SRF
activation by coexpressing activated Ga13 or Gaq with Gbg.
Interestingly, cells coexpressing Ga13QL and Gb1g1 or Gb1g5
showed higher luciferase activities than the sum of the activi-
ties shown by cells expressed Gbg and Ga13 alone. This sug-
gests that Ga13 may work synergistically with Gbg in activa-
tion of SRF. Similar synergistic effects were also observed with
Gaq and Gbg. To confirm the above observation, the Gi-coupled
m2-muscarinic receptor (m2R) was expressed in NIH3T3 cells,
and carbachol-induced SRF-mediated transcription was deter-
mined. As expected, cells expressing m2R showed marginal
carbachol-mediated increases in luciferase activities (Fig. 5A),
which may be attributed to Gbg released from the Gi proteins,
since Gai does not activate SRF (Fig. 1). However, when m2R
was coexpressed with m1R in NIH3T3 cells, there was a syn-
ergistic response to the muscarinic ligand carbachol (Fig. 5B),
i.e. carbachol induced more luciferase activities in cells coex-
pressing m1R and m2R than those expressing m1R or m2R
alone. Furthermore, Pertussis toxin (Ptx), which did not inhibit
the response to carbachol in cells expressing m1R, inhibited the
response to carbachol in cells coexpressing m1R and m2R (Fig.
5B). It appears that Ptx blocked only the part contributed by
m2R. Ptx is a bacteria toxin that ADP-ribosylates the a sub-
units of the Gi, Go, and Gt proteins and blocks the activation of
these G proteins by receptors. Therefore, it is reasonable to
conclude that Gbg works synergistically with Gaq and Ga13 in
regulation of SRF.
The wild-type Ga12 and Ga13, when expressed in NIH3T3
cells, also showed significant stimulation of SRF-mediated
transcription (Fig. 6A), although the activity is usually one-
fifth of that of the QL mutant when the same amount of DNA
is used in transfection (data not shown). The relative high
activities of the wild-type Ga12 and Ga13 may be due to the slow
intrinsic GTPase activities of these Ga subunits (10, 25, 26).
The SRF activation by the wild-type Ga12 and Ga13 allowed us
to test if the RGS proteins could inhibit Ga12/13-mediated ef-
fects. We tested RGS2, RGS4, RGS12, and Axin. RGS2 and
RGS4 are among the well characterized RGS proteins, which
show GTPase-activating protein activities for the Gi and/or Gq
families of a subunits (13, 14, 27, 28). RGS12 (29) and Axin (30)
are two recently cloned proteins that contain the RGS domains
but have not been tested for their abilities to regulate G pro-
tein-mediated signaling. Coexpression of RGS12 significantly
inhibited Ga12- and Ga13-induced SRF activation (Fig. 6A),
whereas RGS2, Axin (Fig. 6A), and RGS4 (data not shown)
showed little effects. Moreover, expression of RGS12 did not
inhibit activated RhoA-mediated SRF activation (data not
shown), indicating that inhibition of Ga12/13-mediated effects
by RGS12 is not due to nonspecific inhibition of downstream
proteins. The inhibition by RGS12 is also unlikely to be the
result of the changes in the expression levels of cotransfected G
proteins, since coexpression of RGS12, Axin, or RGS2 did not
alter the expression levels of Ga12 or Ga13 (Fig. 6E). Therefore,
RGS12 is likely to affect the function of Ga12/13 directly. The
effects of the RGS proteins on LPA and thrombin-mediated
SRF activation were also tested in the Gaq/11-deficient fibro-
blast cell line, where LPA and thrombin-mediated SRF activa-
tion is presumably mediated by the G12 family of G proteins.
The Gaq/11-deficient cells were cotransfected with SRE.L re-
FIG. 4. Dose-dependent stimulation of SRF. The Gq/11-deficient
cells were cotransfected with 0.15 mg of SRE.L-luciferase reporter plas-
mid, 0.15 mg of GFP expression construct, and 0.2 mg of LacZ (A, B), the
endothelin receptor type 1a (C), and thromboxane A2 receptor (D). The
next day, cells were lysed 6 h after the addition of thrombin (A), LPA
(B), endothelin (C), and U46619 (D) with concentrations indicated in
the figure. Data are processed and presented as described in the legend
to Fig. 1.
FIG. 5. Synergistic effects between bg and a subunits in SRF
activation. A, NIH3T3 cells were cotransfected with 0.15 mg of SRE.L-
luciferase reporter plasmid, 0.15 mg of GFP expression construct, and
0.2 mg of LacZ or 0.1 mg of Gb and Gg in the presence or absence of 0.01
mg of activated G protein a subunits. One day later cells were lysed, and
GFP levels and luciferase activity were determined as described in the
legend to Fig. 1. B, NIH3T3 cells were cotransfected with 0.15 mg of
SRE.L-luciferase reporter plasmid, 0.15 mg of GFP expression con-
struct, 0.1 mg of LacZ, 0.05 mg of m1R, and/or 0.15 mg of m2R expression
plasmid as indicated in the figure. One day later, 1 mM carbachol (Car)
was added to cells that were treated with or without 200 ng/ml of Ptx for
2 h. Six hours after the addition of the ligand, cells were lysed, and GFP
levels and luciferase activity were determined as described in the leg-
end to Fig. 1.
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porter plasmids and cDNA encoding RGS2, RGS4, RGS12, or
Axin, and LPA-induced production of luciferase was deter-
mined. Cells expressing RGS12 showed consistently lower lu-
ciferase activities than those expressing the control LacZ,
RGS2, RGS4, or Axin (Fig. 6B). RGS12 was also able to inhibit
thrombin-mediated SRF activation in the Gaq/11-deficient cells
(data not shown). Since RGS12 was able to inhibit Ga12/13 (Fig.
6A), RGS12-mediated attenuation of LPA and thrombin-in-
duced SRF activation may result from the inhibition of endog-
enous Ga12/13 proteins by RGS12 in the Gaq/11-deficient cells.
The effects of RGS12 on other G protein-mediated signaling
pathways were also investigated. RGS12 as well as RGS2,
RGS4, or Axin did not affect b-adrenergic agonist isoprenaline-
induced CRE-mediated gene transcription (Fig. 6C), suggesting
that none of the RGS proteins could inhibit the Gs function.
However, all the RGS proteins except Axin were also able to
inhibit norepinephrine-induced SRF activation in 3T3 cells
expressing a1-AR (Fig. 6D). As demonstrated earlier, a1-AR-
mediated SRF activation is dependent on Gaq/11 proteins.
Thus, inhibition of a1-AR-mediated SRF by the RGS proteins
suggests that these RGS proteins may inhibit Gaq/11. Both
RGS2 and RGS4 were also able to inhibit norepinephrine-
induced phospholipase C activation in COS-7 cells coexpressing
a1-AR.
2 Thus, the action of RGS12 may not be specific to the
G12 class of G proteins.
DISCUSSION
In this report, we have characterized the involvement of G
protein subunits in activation of SRF by a number of GPCRs.
Our findings that Ga12 and Ga13 can activate SRF are consist-
ent with previous reports that Ga12 activates SRF through
RhoA (8) and that Ga12/13 induces formation of stress fibers via
RhoA (7). The literature, however, appears to be inconsistent
with regard to the involvement of Gaq in SRF activation (8, 31).
Our findings described in this report demonstrate that not only
Gaq, but also all other members of this class of G proteins can
activate SRF probably through RhoA. The fact that m1R and
a1-AR use Gaq/11 exclusively in activation of SRF strongly
supports the involvement of Gq in SRF activation. Not all
Gq-coupled receptors, however, activate SRF in Gaq/11-depend-
ent pathways. Receptors, including the endothelin receptors
and thromboxane receptor A2, both of which are known to
couple to Gq to activate phospholipase C, can activate SRF in a
Gaq/11-independent way (32). Moreover, receptors for thrombin
and LPA can also lead to RhoA and SRF activation independ-
ently of Gaq/11, although these two receptors may also be able
to couple to the Gi proteins in addition to the Gq proteins.
Interestingly, among those we tested none of the receptors that
are previously known to predominantly couple to Gi or Gs can
induce activation of SRF in the presence or absence of Gaq/11.
Unlike the Ga subunits of the Gq and G12 classes, the ex-
pression of activated Gao or Gai does not activate SRF. In
addition, Gs does not appear to activate SRF because the b-AR
agonist isoprenaline did not stimulate SRF-mediated tran-
scription in cells expressing b2-AR, while isoprenaline was able
to stimulate CRE-mediated transcription. The inability of b-AR
to activate SRF also suggests that b2-AR cannot couple to
endogenous G12/13 in the fibroblasts. It is also apparent that
m1R and a1-AR as well as a2-AR, b1-AR, the IL-8 receptor, and
D1 and D2 receptors are unable to couple to Ga12 or Ga13,
because these receptors could not activate SRF in the Gaq/11-
deficient cells. The thromboxane A2 and thrombin receptors
were shown previously to couple to Ga12 and Ga13 using dif-
ferent methods (9, 10, 33). Thus, SRF activation by these re-
ceptors should at least in part be mediated by Ga12/13. The LPA
receptor and endothelin receptors may also be able to couple to
Ga12/13 unless there exist yet-to-be identified G protein a sub-
units that can also activate SRF in the Gaq/11-deficient mouse
fibroblast cells. Under the same premise, the inhibition of LPA
and thrombin-induced SRF activation by RGS12 may be attrib-
uted to the inhibition of Ga12/13. In fact, RGS12 can inhibit
recombinant Ga12 and Ga13-mediated SRF activation (Fig. 6A).
The inability of RGS2 and RGS4 to inhibit Ga12/13-, LPA-, or
thrombin-mediated SRF activation indicates that these two
RGS proteins do not act on Ga12/13. Therefore, there is appar-
ent specificity in interactions between RGS proteins and G
proteins. Although Axin contains a RGS domain, it is unable to
regulate any of the known G proteins.
2 D. Wu, unpublished data.
FIG. 6. Effects of RGS proteins on SRF activation. A, NIH3T3
cells were cotransfected with 0.15 mg of SRE.L-luciferase reporter plas-
mid, 0.15 mg of GFP expression construct, and 0.2 mg of LacZ or RGS in
the presence or absence of 0.05 mg of Ga12 or Ga13 subunits. One day
later cells were lysed, and GFP levels and luciferase activity were
determined as described in the legend to Fig. 1. B, the Gaq/11-deficient
cells were cotransfected with 0.15 mg of SRE.L-luciferase reporter plas-
mid, 0.15 mg of GFP expression construct, and 0.2 mg of LacZ or various
RGS expression plasmids. Varying amounts of LPA were added the
next day for 6 h. Then GFP levels and luciferase activity were deter-
mined as described in the legend to Fig. 1. C, NIH3T3 cells were
cotransfected with 0.15 mg of CRE-luciferase reporter plasmid, 0.15 mg
of GFP expression construct, and 0.2 mg of LacZ or RGS expression
plasmids. Isoprenaline (10 mM) was added the next day for 6 h. Then
GFP levels and luciferase activity were determined as described in the
legend to Fig. 1. D, NIH3T3 cells were cotransfected with 0.15 mg of
SRE.L-luciferase reporter plasmid, 0.15 mg of GFP expression con-
struct, 0.1 mg of a1-AR, and 0.1 mg of LacZ or RGS. 1 mM norepinephrine
was added the next day for 6 h. Then GFP levels and luciferase activity
were determined as described in the legend to Fig. 1.
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Gbg subunits are also involved in regulation of SRF, espe-
cially together with Gaq and Ga13. Since SRF is downstream of
the signal cascade, we do not know where the Ga-mediated
pathways interact with the Gbg-mediated ones. It appears that
the interactions are upstream of RhoA because C3 was able to
completely abolish carbachol-mediated effects in cells coex-
pressing m1R and m2R. It is also not clear how Gaq and Ga13
regulate RhoA and SRF. Recent studies suggested that the Tec
family of nonreceptor tyrosine kinases may be regulated by Gaq
(34) and Ga12/13 and that Tec kinases regulate RhoA in a
C3-dependent manner.3 In addition, Gbg was shown to regu-
late Btk, a member of the Tec family, via phosphatidylinositide
3-kinase (35). Thus, the synergistic activation of SRF by Ga
and Gbg may lie in the kinases. Further studies are needed to
better understand these questions.
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